Published in PLoS One on January 21, 2014
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci (2016) 0.94
MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther (2014) 0.86
The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol (2015) 0.86
Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene (2014) 0.85
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer. Int J Clin Exp Med (2015) 0.82
MicroRNA‑144 inhibits migration and proliferation in rectal cancer by downregulating ROCK‑1. Mol Med Rep (2015) 0.81
Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. World J Gastroenterol (2015) 0.80
Unavoidable human errors of tumor size measurement during specimen attachment after endoscopic resection: a clinical prospective study. PLoS One (2015) 0.78
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy. Oncotarget (2016) 0.78
The role of microRNAs in gallbladder cancer. Mol Clin Oncol (2016) 0.77
ROCK1 as a novel prognostic marker in vulvar cancer. BMC Cancer (2014) 0.77
Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. Oncol Lett (2017) 0.76
Novel Insights into the Roles of Rho Kinase in Cancer. Arch Immunol Ther Exp (Warsz) (2016) 0.76
Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development. Proc Natl Acad Sci U S A (2016) 0.75
The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer. Gastroenterol Res Pract (2016) 0.75
RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells. Oncotarget (2016) 0.75
miR-506 suppresses neuroblastoma metastasis by targeting ROCK1. Oncol Lett (2016) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer (2011) 18.34
Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet (2009) 16.58
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer (2000) 8.85
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56
Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut (2008) 4.07
Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol (2005) 3.63
Loss of mir-146a function in hormone-refractory prostate cancer. RNA (2008) 3.35
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res (2008) 3.06
The cytoskeleton and cancer. Cancer Metastasis Rev (2009) 2.70
Implications of micro-RNA profiling for cancer diagnosis. Oncogene (2006) 2.01
Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology (2012) 1.91
MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res (2011) 1.80
Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg (2007) 1.74
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol (2006) 1.69
Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep (2012) 1.66
Molecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assay. Ann Surg Oncol (2011) 1.63
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood (2009) 1.45
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet (2011) 1.41
Epithelial-mesenchymal transition. Cancer Res (2008) 1.37
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Carcinogenesis (2012) 1.27
New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol (2012) 1.23
Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene (2011) 1.18
The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol (2012) 1.17
Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg (2006) 1.15
Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci (2012) 1.15
Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer (2010) 1.13
Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One (2011) 1.11
Lymphatic involvement in early gastric cancer: prevalence and prognosis in France. Arch Surg (2000) 1.09
miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer (2012) 1.08
Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery. World J Gastroenterol (2004) 1.01
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Cancer Biol Ther (2012) 0.99
Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells. Hepatogastroenterology (2013) 0.89
Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem (2013) 0.87
The future of sentinel node oriented tailored approach in patients with early gastric cancer. J Gastric Cancer (2012) 0.86
Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma. Asia Pac J Clin Oncol (2013) 0.86
Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol (2013) 0.85
Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer. PLoS One (2013) 0.84
Long-term survival after endoscopic resection versus surgery in early gastric cancers. Endoscopy (2015) 1.72
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer (2014) 1.31
Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc (2014) 1.08
The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer. Helicobacter (2014) 1.04
Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc (2014) 1.02
Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc (2014) 0.92
Therapeutic Decision-Making Using Endoscopic Ultrasonography in Endoscopic Treatment of Early Gastric Cancer. Gut Liver (2016) 0.91
Stricture occurring after endoscopic submucosal dissection for esophageal and gastric tumors. Clin Endosc (2014) 0.89
Cost comparison between surgical treatments and endoscopic submucosal dissection in patients with early gastric cancer in Korea. Gut Liver (2015) 0.88
Endoscopic management of tumor bleeding from inoperable gastric cancer. Clin Endosc (2015) 0.83
Effects of polymorphisms of innate immunity genes and environmental factors on the risk of noncardia gastric cancer. Cancer Res Treat (2013) 0.80
Short-Term Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver (2016) 0.80
Nonexposure endolaparoscopic full-thickness resection with simple suturing technique. Endoscopy (2015) 0.79
Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver (2017) 0.79
Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study. Cancer Res Treat (2015) 0.77
Endoscopic removal of a migrated coil after embolization of a splenic pseudoaneurysm: a case report. Clin Endosc (2014) 0.77
Comparison of the long-term results of patients who underwent laparoscopy versus open distal gastrectomy. Surg Endosc (2015) 0.77
Gastric preparation for upper endoscopy. Clin Endosc (2012) 0.77
Upper endoscopy in international digestive endoscopy network 2012: towards upper end of quality. Clin Endosc (2012) 0.76
Phlegmonous Gastritis with Early Gastric Cancer. J Gastric Cancer (2016) 0.75
Highlights from the 50th seminar of the korean society of gastrointestinal endoscopy. Clin Endosc (2014) 0.75
Highlights from the 52nd Seminar of the Korean Society of Gastrointestinal Endoscopy. Clin Endosc (2015) 0.75
Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection. J Gastric Cancer (2016) 0.75
International digestive endoscopy network 2014: turnpike to the future. Clin Endosc (2014) 0.75
Are there great savings with rapid urease test by one-plus-one? Clin Endosc (2012) 0.75
Role of Clinical Endoscopy in Emphasizing Endoscope Disinfection. Clin Endosc (2015) 0.75
Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea. Gut Liver (2017) 0.75
Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification. Gut Liver (2017) 0.75
Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages. Helicobacter (2017) 0.75
Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience. J Gastric Cancer (2017) 0.75
Interobserver agreement in using magnifying narrow band imaging system. Clin Endosc (2014) 0.75
Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. J Gastric Cancer (2017) 0.75